Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Identification of microenvironment features associated with primary resistance to anti-PD-1/PD-L1 + antiangiogenesis in gastric cancer through spatial transcriptomics and plasma proteomics.

  • Authors : Cousin S; Department of Medicine, Institut Bergonié, 229 cours de l'Argonne, Bordeaux, 33000, France.; Guégan JP

Subjects: Tumor Microenvironment*/Tumor Microenvironment*/Tumor Microenvironment*/drug effects ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/drug therapy ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/genetics

  • Source: Molecular cancer [Mol Cancer] 2024 Sep 13; Vol. 23 (1), pp. 197. Date of Electronic Publication: 2024 Sep 13.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
Editorial & Opinion

Implications of PD-L1 expression on the immune microenvironment in HER2-positive gastric cancer.

  • Authors : Chen Y; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing, China.; Jia K

Subjects: Tumor Microenvironment*/Tumor Microenvironment*/Tumor Microenvironment*/immunology ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/immunology ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/genetics

  • Source: Molecular cancer [Mol Cancer] 2024 Aug 20; Vol. 23 (1), pp. 169. Date of Electronic Publication: 2024 Aug 20.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Strong capacity of differentiated PD-L1 CAR-modified UCB-CD34 + cells and PD-L1 CAR-modified UCB-CD34 + -derived NK cells in killing target cells and restoration of the anti-tumor function of PD-1-high exhausted T Cells.

  • Authors : Ghaedrahmati F; Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, 81744, Iran.; Akbari V

Subjects: Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/immunology ; Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/metabolism ; B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/metabolism

  • Source: Stem cell research & therapy [Stem Cell Res Ther] 2024 Aug 13; Vol. 15 (1), pp. 257. Date of Electronic Publication: 2024 Aug 13.Publisher: BioMed Central Country of Publication: England NLM ID: 101527581 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

LINC00460/miR-186-3p/MYC feedback loop facilitates colorectal cancer immune escape by enhancing CD47 and PD-L1 expressions.

  • Authors : Luo Q; Department of Gastroenterology and Hepatology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510180, China.; Guangzhou Key Laboratory of Digestive Diseases, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510180, China.

Subjects: Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/genetics ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/pathology ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/metabolism

  • Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Aug 13; Vol. 43 (1), pp. 225. Date of Electronic Publication: 2024 Aug 13.Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy.

  • Authors : Su X; The First Clinical Medical College of Gansu University of Chinese Medicine (Gansu Provincial Hospital), Lanzhou, 730000, China.; Department of General Surgery, Gansu Provincial Hospital, No. 204 Donggang West Road, Chengguan District, Lanzhou, 730000, China.

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/immunology ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Neoplasms*/Neoplasms*/Neoplasms*/therapy

  • Source: Journal of translational medicine [J Transl Med] 2024 Aug 09; Vol. 22 (1), pp. 751. Date of Electronic Publication: 2024 Aug 09.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

BRAF mutant PD-L1 positive metastatic musculoskeletal lesions from primary lung adenocarcinoma treated with combination vemurafenib and pembrolizumab: a case report.

  • Authors : Ngelangel CA; University of the Philippines-Philippine General Hospital Division of Medical Oncology, Manila, Philippines. .; Asian Cancer Institute-Asian Hospital & Medical Center, Muntinlupa City, Philippines. .

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Proto-Oncogene Proteins B-raf*/Proto-Oncogene Proteins B-raf*/Proto-Oncogene Proteins B-raf*/genetics ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy

  • Source: Journal of medical case reports [J Med Case Rep] 2024 Sep 28; Vol. 18 (1), pp. 450. Date of Electronic Publication: 2024 Sep 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101293382 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

The expansion of MDSCs induced by exosomal PD-L1 promotes the progression of gastric cancer.

  • Authors : Li H; Jiangsu Province Key Laboratory of Tumor Systems Biology and Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, 155 Hanzhong Road, Nanjing, 210029, Jiangsu, China.; No.1 Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210023, Jiangsu, China.

Subjects: B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/metabolism ; Exosomes*/Exosomes*/Exosomes*/metabolism ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/pathology

  • Source: Journal of translational medicine [J Transl Med] 2024 Sep 03; Vol. 22 (1), pp. 821. Date of Electronic Publication: 2024 Sep 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

NDR1 mediates PD-L1 deubiquitination to promote prostate cancer immune escape via USP10.

  • Authors : Fu M; Department of Urology, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361101, China.; Li J

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/immunology ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/metabolism

  • Source: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Sep 03; Vol. 22 (1), pp. 429. Date of Electronic Publication: 2024 Sep 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

LAMTOR1 decreased exosomal PD-L1 to enhance immunotherapy efficacy in non-small cell lung cancer.

  • Authors : Wu B; Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, 110136, China.; Huang X

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/immunology ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy

  • Source: Molecular cancer [Mol Cancer] 2024 Sep 02; Vol. 23 (1), pp. 184. Date of Electronic Publication: 2024 Sep 02.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the "all-around warrior" in immunotherapy.

  • Authors : Liu Q; Department of Urology, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, 110042, China.; Guan Y

Subjects: B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/metabolism ; Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/metabolism ; Immunotherapy*/Immunotherapy*/Immunotherapy*/methods

  • Source: Molecular cancer [Mol Cancer] 2024 Sep 02; Vol. 23 (1), pp. 183. Date of Electronic Publication: 2024 Sep 02.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

×
  • 1-10 ل  578 نتائج ل ""B7-H1 Antigen""